Dr. Karen Seiter discusses the efficacy and safety considerations in using ponatinib.
For more information, tools, resources and CE activities please http://managingcml.com/
Managing CML is an educational online community for health care professionals who provide care to patients with chronic myelogenous leukemia, or CML. Our mission is to provide ongoing evidence-based scientific data and the most up-to-date information, tools, and resources for treating this hematologic malignancy in your clinical practice.
Advertisement